Prognostic role of platelet to lymphocyte and lymphocyte to monocyte ratios in advanced melanoma treated with antiprogrammed death-1
- 2 Downloads
Unable to display preview. Download preview PDF.
- 4.Nakamura Y, Kitano S, Takahashi A, et al. Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy. Oncotarget 2016; 7: 77404–15.Google Scholar
© John Libbey Eurotext 2018